Lidocaine, lindane, neomycin, nystatin, triamcinolone acetonide (Oridermyl)
Lidocaine, lindane, neomycin, nystatin, triamcinolone acetonide
Bayer (Pty) Ltd (Animal Health Division)
Every registration of this product has been cancelled.
Registration
- Applicant
- Bayer (Pty) Ltd (Animal Health Division)
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Oridermyl EACH 10 g CONTAINS LIDOCAINE A 200,0 mg LINDANE A 50,0 mg NEOMYCIN SULPHATE A 45,161 mg NYSTATIN A 208,03 mg TRIAMCINOLONE ACETONIDE A 10,0 mg | Not listed | 83/795 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.